News & Press Releases

Mintz is pleased to have represented Royal Philips, a global leader in health technology, in the sale of its Emergency Care business to Emergency Care Holdings, a platform backed by Bridgefield Capital. The Emergency Care business offers products that play a critical role in acute care management, both inside and outside the hospital, including cardiac resuscitation, such as automated external defibrillators, and emergency care devices for professional and consumer applications. Following the sale, the business now operates as Heartstream and continues to market select products under a brand license with Philips.

Member Theresa Carnegie was quoted by Bloomberg Law in an article about the Trump Administration’s new drug-pricing models, which aim to align Medicare drug prices with lower international prices. The article notes that the pharmaceutical industry is raising legal questions about whether CMS has the authority to implement the two new pricing demonstrations.

The Journal of Pension Benefits published an article written by Of Counsel Michelle Capezza about 401(k) retirement plans and the need to assist plan participants in managing their retirement assets in the decumulation phase. Michelle writes that plan sponsors should consider how to improve their retirement programs to address this need.

Mintz advised Altamira Technologies Corporation, an open-source technology company in the national security space, on its acquisition by Parsons Corporation, a leading national security and global infrastructure technology provider. The transaction is valued at $375 million, including $330 million in cash at closing and an additional $45 million earn-out contingent on 2026 EBITDA targets.

Mintz advised the placement agents in connection with a $1 billion registered direct offering of 19,000,000 shares of common stock and, in lieu of common stock, pre-funded warrants to purchase up to 41,790,274 shares of common stock. Each share of common stock and each pre-funded warrant was sold with a common stock warrant to purchase two shares of common stock. 

Mintz advised the underwriters in connection with a $661 million public offering by Praxis Precision Medicines of 2,543,800 shares of common stock (which includes 331,800 shares of common stock issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock) at a public offering price of $260.00 per share.